机构:
Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
Univ Penn, Sch Med, Philadelphia, PA 19104 USAChildrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
Kwiatkowski, Janet L.
[1
,2
]
机构:
[1] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
Effective chelation therapy can prevent or reverse organ toxicity related to iron overload, yet cardiac complications and premature death continue to occur, largely related to difficulties with compliance in patients who receive parenteral therapy. The use of oral chelators may be able to overcome these difficulties and improve patient outcomes. A chelator's efficacy at cardiac and liver iron removal and side-effect profile should be considered when tailoring individual chelation regimens. Broader options for chelation therapy, including possible combination therapy, should improve clinical efficacy and enhance patient care.
机构:
Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
Univ Penn, Sch Med, Philadelphia, PA 19104 USAChildrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
机构:
Fortis Mem Res Inst, Pediat Hematol Oncol & Bone Marrow Transplant Uni, Dept Pediat, Gurgaon, Haryana, IndiaFortis Mem Res Inst, Pediat Hematol Oncol & Bone Marrow Transplant Uni, Dept Pediat, Gurgaon, Haryana, India